Federal (United States) · Session law
Title XI
9 sections
9 sections
- Pub. L. 110-85, tit. XI, subtit. A, sec. 1101POLICY ON THE REVIEW AND CLEARANCE OF SCIENTIFIC ARTICLES PUBLISHED BY FDA EMPLOYEES.Enacted
- Pub. L. 110-85, tit. XI, subtit. A, sec. 1102PRIORITY REVIEW TO ENCOURAGE TREATMENTS FOR TROPICAL DISEASES.Enacted
- Pub. L. 110-85, tit. XI, subtit. A, sec. 1103IMPROVING GENETIC TEST SAFETY AND QUALITY.Enacted
- Pub. L. 110-85, tit. XI, subtit. A, sec. 1104NIH TECHNICAL AMENDMENTS.Enacted
- Pub. L. 110-85, tit. XI, subtit. A, sec. 1105SEVERABILITY CLAUSE.Enacted
- Pub. L. 110-85, tit. XI, subtit. B, sec. 1111IDENTIFICATION OF CLINICALLY SUSCEPTIBLE CONCENTRATIONS OF ANTIMICROBIALS.Enacted
- Pub. L. 110-85, tit. XI, subtit. B, sec. 1112ORPHAN ANTIBIOTIC DRUGS.Enacted
- Pub. L. 110-85, tit. XI, subtit. B, sec. 1113EXCLUSIVITY OF CERTAIN DRUGS CONTAINING SINGLE ENANTIOMERS.Enacted
- Pub. L. 110-85, tit. XI, subtit. B, sec. 1114REPORT.Enacted